SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jason Patty who wrote (12)8/3/1996 10:23:00 PM
From: Zvi Yammer   of 371
 
Leukoscan is assumed to be approved in Europe early Septemper. FDA submission will be immediately following approval.
FDA approval should be about 12 months after submission.
IR number is 201-605-8200. IR man is Paul Heron. Give him a call he's real easy to talk to and he always returns calls if you leave him a voice mail.
When you get your answers to the other two questions please post.

Thanks

Zvi
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News